Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 1475 entries
View as:

A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Pharmacokinetics of BMS-986177 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02807909 Org: User:
Start: 07/31/16 End: 08/31/16 Due: 08/31/17

A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02864251 Org: User:
Start: 03/17/17 End: 10/17/22 Due: 10/17/23

Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT00306878 Org: User:
Start: 08/31/95 End: 05/31/97 Due: 05/31/98

A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05615012 Org: User:
Start: 11/11/22 End: 12/13/23 Due: 12/13/24

A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan

Phase: N/A Priority: Normal
NCT ID: NCT03273790 Org: User:
Start: 04/01/17 End: 12/31/18 Due: 12/31/19

A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Melanoma in Real-World Conditions in France

Phase: N/A Priority: Normal
NCT ID: NCT04550247 Org: User:
Start: 09/02/20 End: 03/15/27 Due: 03/15/28

A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00390936 Org: User:
Start: 10/31/07 End: 03/31/10 Due: 03/31/11

An Investigational Study to Evaluate the Effect of Rifampin on the Singe Dose of Experimental Medication BMS-986224 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03563950 Org: User:
Start: 06/01/18 End: 07/27/18 Due: 07/27/19

A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia

Phase: N/A Priority: Normal
NCT ID: NCT00002067 Org: User:
Start: - End: - Due: -

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00004584 Org: User:
Start: 12/31/99 End: 01/31/02 Due: 01/31/03

Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00908024 Org: User:
Start: 10/31/09 End: 12/31/12 Due: 12/31/13

An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT03739788 Org: User:
Start: 12/05/18 End: 02/11/19 Due: 02/11/20

A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT02998528 Org: User:
Start: 03/04/17 End: 12/06/24 Due: 12/06/25

A Study to Investigate the Effects of Gastric Acid Suppression by Rabeprazole and BMS-986165 on How Fast and Complete The Drug is Absorbed Into the Body of Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03979248 Org: User:
Start: 05/16/19 End: 07/07/19 Due: 07/07/20

Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil

Phase: N/A Priority: Normal
NCT ID: NCT04039373 Org: User:
Start: 07/22/19 End: 10/16/19 Due: 10/16/20

An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT05369832 Org: User:
Start: 12/16/22 End: 04/11/25 Due: 04/11/26

A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks

Phase: N/A Priority: Normal
NCT ID: NCT02713867 Org: User:
Start: 05/24/16 End: 01/18/22 Due: 01/18/23

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT04772079 Org: User:
Start: 03/23/21 End: 09/08/33 Due: 09/08/34

Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT01673867 Org: User:
Start: 11/02/12 End: 12/17/21 Due: 12/17/22

Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib

Phase: N/A Priority: Normal
NCT ID: NCT01593254 Org: User:
Start: 09/12/12 End: 04/12/22 Due: 04/12/23

A Study to Evaluate the Drug Levels and Safety of Pegbelfermin in Healthy Overweight and Obese Chinese and Korean Participants

Phase: N/A Priority: Normal
NCT ID: NCT04649710 Org: User:
Start: 06/21/21 End: 09/22/21 Due: 09/22/22

Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00780000 Org: User:
Start: 04/30/08 End: 06/30/08 Due: 06/30/09

A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam

Phase: N/A Priority: Normal
NCT ID: NCT05901714 Org: User:
Start: 06/14/23 End: 04/11/24 Due: 04/11/25

Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period

Phase: N/A Priority: Normal
NCT ID: NCT02531269 Org: User:
Start: 03/31/15 End: 02/29/16 Due: 02/28/17

A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04116632 Org: User:
Start: 09/30/19 End: 02/10/20 Due: 02/10/21